Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
2 hedge funds and large institutions have $16K invested in Kitov Pharma Ltd. Warrants in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 1 → 2 (+1)
33% more capital invested
Capital invested by funds: $12K → $16K (+$4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.37K |
KTOVW Hedge Fund Activity: Q3 2017 in Review
2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2017, worth a combined $16K — up 33% from $12K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new KTOVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $1.45K. The largest seller was Susquehanna International Group, cutting an estimated $4.37K.
- 2 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2017, up from 1 in Q2 2017.
- Funds reported $16K of Kitov Pharma Ltd. Warrants stock for Q3 2017, up 33% quarter-over-quarter.
- 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q3 2017 and 0 closed out, a net change of +1 holder.
- The largest Kitov Pharma Ltd. Warrants buyer in Q3 2017 was UBS Group, an estimated $1.45K added.
- The largest Kitov Pharma Ltd. Warrants seller in Q3 2017 was Susquehanna International Group, an estimated $4.37K sold.
Based on aggregated 13F filings for Q3 2017.